ZA200007396B - Method of treatment. - Google Patents

Method of treatment.

Info

Publication number
ZA200007396B
ZA200007396B ZA200007396A ZA200007396A ZA200007396B ZA 200007396 B ZA200007396 B ZA 200007396B ZA 200007396 A ZA200007396 A ZA 200007396A ZA 200007396 A ZA200007396 A ZA 200007396A ZA 200007396 B ZA200007396 B ZA 200007396B
Authority
ZA
South Africa
Prior art keywords
treatment
Prior art date
Application number
ZA200007396A
Inventor
Martin Steiner
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA200007396B publication Critical patent/ZA200007396B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ZA200007396A 1998-06-16 2000-12-12 Method of treatment. ZA200007396B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9812941.4A GB9812941D0 (en) 1998-06-16 1998-06-16 Method of treatment

Publications (1)

Publication Number Publication Date
ZA200007396B true ZA200007396B (en) 2002-02-27

Family

ID=10833832

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200007396A ZA200007396B (en) 1998-06-16 2000-12-12 Method of treatment.

Country Status (20)

Country Link
EP (1) EP1087766A4 (en)
JP (1) JP2002518330A (en)
KR (1) KR20010052895A (en)
CN (1) CN1305379A (en)
AP (1) AP2000002002A0 (en)
AU (1) AU740749B2 (en)
BG (1) BG105127A (en)
BR (1) BR9911150A (en)
CA (1) CA2335236A1 (en)
CZ (1) CZ20004698A3 (en)
EA (1) EA003584B1 (en)
GB (1) GB9812941D0 (en)
HU (1) HUP0102507A3 (en)
IL (1) IL139943A0 (en)
NO (1) NO20006383D0 (en)
NZ (1) NZ508532A (en)
PL (1) PL345261A1 (en)
SK (1) SK19192000A3 (en)
WO (1) WO1999065491A1 (en)
ZA (1) ZA200007396B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004507504A (en) * 2000-08-28 2004-03-11 シントン・ベスローテン・フェンノートシャップ Paroxetine composition and method for producing the same
US7396542B2 (en) * 2001-12-28 2008-07-08 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
WO2006023347A1 (en) * 2004-08-20 2006-03-02 Alpharma, Inc. Paroxetine formulations
FR2926221A1 (en) * 2008-01-14 2009-07-17 Tassin Thomas COMPOSITIONS FOR THE ARTIFICIAL REPRODUCTION OF THE PHARMACOLOGICAL CONDITIONS OF ADDICTIVE DRUG DEPENDENCE SUCH AS OPIACES, PSYCHOSTIMULANTS, TOBACCO AND ALCOHOL, BY COMBINING NICOTINE AND A LIGAND.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058061T3 (en) * 1985-10-25 1994-11-01 Beecham Group Plc DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT.
AU658155B2 (en) * 1990-11-24 1995-04-06 Beecham Group Plc Use of paroxetine for the treatment of senile dementia, or anorexia
AR001982A1 (en) * 1995-02-06 1998-01-07 Smithkline Beecham Plc PAROXETINE CHLORHYDRATE ANHYDRATED, AND PROCEDURE FOR ITS PREPARATION
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method

Also Published As

Publication number Publication date
CN1305379A (en) 2001-07-25
JP2002518330A (en) 2002-06-25
HUP0102507A3 (en) 2003-12-29
SK19192000A3 (en) 2001-05-10
CZ20004698A3 (en) 2002-02-13
KR20010052895A (en) 2001-06-25
CA2335236A1 (en) 1999-12-23
EA200100041A1 (en) 2001-06-25
GB9812941D0 (en) 1998-08-12
EP1087766A4 (en) 2001-11-21
AU4688599A (en) 2000-01-05
AU740749B2 (en) 2001-11-15
NO20006383L (en) 2000-12-14
AP2000002002A0 (en) 2000-12-31
EP1087766A1 (en) 2001-04-04
WO1999065491A1 (en) 1999-12-23
BR9911150A (en) 2001-03-06
EA003584B1 (en) 2003-06-26
BG105127A (en) 2001-11-30
HUP0102507A2 (en) 2002-05-29
NZ508532A (en) 2003-08-29
IL139943A0 (en) 2002-02-10
PL345261A1 (en) 2001-12-03
NO20006383D0 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
GB9824436D0 (en) Methods of treatment
ZA200108446B (en) Novel method of treatment.
ZA986363B (en) Novel method of treatment.
GB9800942D0 (en) Well treatment
ZA985237B (en) Novel method of treatment.
ZA986364B (en) Novel method of treatment.
ZA986365B (en) Novel method of treatment.
PL341667A1 (en) Method of treating cooped
ZA977867B (en) Method of treatment.
GB9714841D0 (en) Treatment method
ZA200007396B (en) Method of treatment.
HK1039565A1 (en) Method of treating endotoxemia.
AP2005003432A0 (en) Novel method of treatment.
GB9822681D0 (en) Method of treatment
ZA985238B (en) Novel method of treatment.
ZA985235B (en) Novel method of treatment.
ZA985236B (en) Novel method of treatment.
GB9822459D0 (en) Method of treatment
GB9808479D0 (en) Method of treatment
GB9818776D0 (en) Method of treatment
GB9811961D0 (en) Method of treatment
ZA995727B (en) Method of treatment of animals.
EG24158A (en) Novel method of treatment
GB9824871D0 (en) Novel method of treatment
GB9824789D0 (en) Novel method of treatment